Investor Alert

Company Close Updates

May 17, 2022, 4:31 p.m. EDT

Moderna Inc. stock outperforms market on strong trading day

MarketWatch Automation

Shares of Moderna Inc. (NAS:MRNA) advanced 4.42% to $142.28 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index (NASDAQ:COMP) rising 2.76% to 11,984.52 and the Dow Jones Industrial Average (DOW:DJIA) rising 1.34% to 32,654.59. Moderna Inc. closed $355.21 short of its 52-week high ($497.49), which the company reached on August 10th.

The stock outperformed some of its competitors Tuesday, as AbbVie Inc. (NYS:ABBV) fell 0.44% to $154.78, Amgen Inc. (NAS:AMGN) rose 0.61% to $245.35, and AstraZeneca PLC ADR (NAS:AZN) rose 1.78% to $65.64. Trading volume (5.9 M) remained 1.3 million below its 50-day average volume of 7.2 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.